Creatine fails to ease concussion symptoms in early trial
NCT ID NCT06644131
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether taking creatine monohydrate daily for seven weeks could reduce persistent symptoms after a mild concussion. 34 adults aged 20-45 who had symptoms for 6-18 months took part. The results showed no clear benefit compared to placebo or usual care, but the study was small and designed mainly to test feasibility.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONCUSSION (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of southern Denmark
Odense, 5230, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Eye-Tracking goggles could spot hidden brain injuries
- Can tailored magnetic pulses quiet a concussed brain?
- Could a smartphone app help teens recover from concussion?
- New study aims to predict concussion recovery in children using symptoms and biology
- Can a common supplement help heal concussions faster?